FierceBiotech 2026年2月5日 Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate
FierceBiotech 2026年2月5日 FDA’s rare pediatric disease voucher program revived by 2026 government funding bill
FierceBiotech 2026年2月4日 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
FierceBiotech 2026年2月4日 Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform
FierceBiotech 2026年2月4日 NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable
FierceBiotech 2026年2月4日 Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech 2026年2月4日 Amgen advances toward lupus redemption while gastric cancer candidate struggles
FierceBiotech 2026年2月4日 NIH turmoil takes center stage as director acknowledges no vaccine-autism link
FierceBiotech 2026年2月3日 Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges
FierceBiotech 2026年2月3日 Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed
FierceBiotech 2026年2月3日 FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases